403
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of Generic Atorvastatin in a Real-World Setting

, , ORCID Icon, , , & ORCID Icon show all
Pages 45-51 | Published online: 05 Mar 2021

References

  • GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–171. doi:10.1016/S0140-6736(14)61682-225530442
  • Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–952. doi:10.1016/S0140-6736(04)17018-915364185
  • Roncaglioni MC, Santoro L, D’Avanzo B, et al. Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM investigators. Circulation. 1992;85(6):2065–2072. doi:10.1161/01.CIR.85.6.20651591825
  • Genest JJ Jr, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85(6):2025–2033. doi:10.1161/01.CIR.85.6.20251534286
  • Das M, Choudhury S, Maity S, et al. Generic versus branded medicines: an observational study among patients with chronic diseases attending a public hospital outpatient department. J Nat Sci Biol Med. 2017;8(1):26–31. doi:10.4103/0976-9668.19835128250671
  • Akunne OO, Godman B, Adedapo AD, Truter I, Fadare J. Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future. J Comp Eff Res. 2016;5(3):281–288. doi:10.2217/cer.15.6527097045
  • Kim SH, Seo MK, Yoon MH, Choi DH, Hong TJ, Kim HS. Assessment of the efficacy and tolerability of 2 formulations of atorvastatin in Korean adults with hypercholesterolemia: a multicenter, prospective, open-label, randomized trial. Clin Ther. 2013;35(1):77–86. doi:10.1016/j.clinthera.2012.11.00923274145
  • Kim SH, Park K, Hong SJ, et al. Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: a multicenter, prospective, randomized, double-blind, double-dummy clinical trial. Clin Ther. 2010;32(11):1896–1905. doi:10.1016/j.clinthera.2010.10.00421095484
  • Boh M, Opolski G, Poredos P, Ceska R, Jezovnik M. Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk. Int Angiol. 2011;30(4):366–374.21747355
  • Ong LM, Punithavathi N, Lena YL, Mahanim O, Leekha S; Storvas Clinical Trial Study Group. Long-term efficacy and safety of a generic atorvastatin in usual clinical care setting. Med J Malaysia. 2011;66(3):214–219.22111443
  • Loch A, Bewersdorf JP, Kofink D, Ismail D, Abidin IZ, Veriah RS. Generic atorvastatin is as effective as the brand-name drug (LIPITOR®) in lowering cholesterol levels: a cross-sectional retrospective cohort study. BMC Res Notes. 2017;10(1):291. doi:10.1186/s13104-017-2617-628716156
  • Wang KY, Ting CT. A randomized, double-blind, placebo-controlled, 8-week study to evaluate the efficacy and safety of once daily atorvastatin (10 mg) in patients with elevated LDL-cholesterol. Jpn Heart J. 2001;42(6):725–738. doi:10.1536/jhj.42.72511933922
  • Rahalkar AR, Ban MR, Hegele RA. Clinical equivalence of proprietary and generic atorvastatin in lipid clinic patients. Can J Cardiol. 2013;29(4):418–422. doi:10.1016/j.cjca.2012.05.01022840301
  • McTaggart F, Jones P. Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit. Cardiovasc Drugs Ther. 2008;22(4):321–338. doi:10.1007/s10557-008-6113-z18553127
  • Clarke AT, Johnson PC, Hall GC, Ford I, Mills PR. High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort. PLoS One. 2016;11(3):e0151587. doi:10.1371/journal.pone.015158726983033
  • Sawunyavisuth B. What are predictors for a continuous positive airway pressure machine purchasing in obstructive sleep apnea patients? Asia Pac J Sci Technol. 2018;23:APST-23-03–10.
  • Kingkaew N, Antadech T. Cardiovascular risk factors and 10-year CV risk scores in adults aged 30–70 years old in Amnat Charoen Province, Thailand. Asia Pac J Sci Technol. 2019;24: APST-24-04–04.
  • Buttichak A, Leelayuwat N, Bumerraj S, Boonprakob Y. The effects of a yoga training program with fit ball on the physical fitness and body composition of overweight or obese women. Asia Pac J Sci Technol. 2019;24:APST-24-02–07.